Sanara MedTech Inc. (NASDAQ:SMTI)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $36.80, but opened at $40.76. Sanara MedTech shares last traded at $37.00, with a volume of 8 shares changing hands.
The stock’s 50-day simple moving average is $37.11 and its 200 day simple moving average is $38.18. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.71. The company has a market capitalization of $233.38 million, a PE ratio of -28.68 and a beta of 2.43.
Several hedge funds and other institutional investors have recently bought and sold shares of SMTI. Arete Wealth Advisors LLC purchased a new position in shares of Sanara MedTech in the 4th quarter valued at $247,000. Citigroup Inc. purchased a new position in shares of Sanara MedTech in the 4th quarter valued at $85,000. ExodusPoint Capital Management LP purchased a new position in shares of Sanara MedTech in the 4th quarter valued at $515,000. Finally, Diametric Capital LP purchased a new position in shares of Sanara MedTech in the 4th quarter valued at $285,000.
Sanara MedTech Inc develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder that helps in the natural wound healing process; BiakoÂ¯s Antimicrobial Skin & Wound Cleanser, a patented wound cleansing spray that disrupts extracellular polymeric substances to eradicate biofilm; and BiakoÂ¯s Antimicrobial Skin & Wound Irrigation Solution that works to irrigate and remove microbes from the wound bed to help eliminate planktonic, immature, and mature biofilms.
Featured Article: Strike Price
Receive News & Ratings for Sanara MedTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanara MedTech and related companies with MarketBeat.com's FREE daily email newsletter.